Berkeley Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-36,897
| Closed | -$2.14M | – | 71 |
|
|
2023
Q3 | $2.14M | Sell |
36,897
-8,110
| -18% | -$471K | 1.46% | 21 |
|
|
2023
Q2 | $2.88M | Buy |
45,007
+4,084
| +10% | +$261K | 1.94% | 19 |
|
|
2023
Q1 | $2.84M | Buy |
40,923
+1,812
| +5% | +$126K | 2.06% | 17 |
|
|
2022
Q4 | $2.81M | Sell |
39,111
-29
| -0.1% | -$2.09K | 2.12% | 16 |
|
|
2022
Q3 | $2.78M | Buy |
39,140
+1,308
| +3% | +$93K | 2.34% | 13 |
|
|
2022
Q2 | $2.91M | Buy |
37,832
+1,083
| +3% | +$83.4K | 2.33% | 12 |
|
|
2022
Q1 | $2.68M | Buy |
36,749
+9,815
| +36% | +$717K | 1.87% | 14 |
|
|
2021
Q4 | $1.68M | Buy |
26,934
+10,278
| +62% | +$641K | 1.12% | 30 |
|
|
2021
Q3 | $986K | Buy |
16,656
+1,114
| +7% | +$65.9K | 0.73% | 39 |
|
|
2021
Q2 | $1.04M | Buy |
15,542
+4,019
| +35% | +$269K | 0.74% | 38 |
|
|
2021
Q1 | $727K | Buy |
+11,523
| New | +$727K | 0.54% | 47 |
|